Amino.Desk

Rapamycin (sirolimus)

Updated Nov 17, 2026 · Clinical review: pending

Rapamycin, also called sirolimus, is a prescription drug approved to prevent kidney transplant rejection. It is not a peptide. It extends lifespan in mice more reliably than any other drug, and many people take it off-label hoping for the same. The first year-long human trial did not meet its main goal.

What it is

Rapamycin blocks mTOR, a switch inside cells that drives growth. At transplant doses, taken daily, it suppresses the immune system. The longevity idea is that a lower dose taken once a week might slow aging without that effect. Whether it does is the open question.

What the evidence shows

PEARL did not test whether rapamycin slows aging or extends life. No human trial has.

Legal status

Label and trial dosing

For the rare lung disease, the label starts at 2 mg a day and adjusts the dose to a target blood level. Transplant dosing is also guided by blood levels.

The longevity trial used something different: 5 mg or 10 mg once a week. That is what was tested, in a monitored study. It is not a label dose and not a recommendation.

Safety

Common questions

Is rapamycin a peptide?

No. It is a small-molecule prescription drug taken by mouth.

Does rapamycin slow aging in humans?

Nobody knows. It extends lifespan in mice. The one year-long human trial did not test aging itself and missed its main goal, which was reducing belly fat.

Is rapamycin FDA-approved for longevity?

No. It is approved for kidney transplant and a rare lung disease. Longevity use is off-label.

What dose did the longevity trial use?

5 mg or 10 mg once a week for 48 weeks, in a monitored study.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy